About Transcatheter Technologies
Transcatheter Technologies is a company based in Regensburg (Germany) founded in 2009 was acquired by Venus MedTech in April 2016. Transcatheter Technologies has raised $6.7 million across 4 funding rounds from investors including Venus MedTech, KfW and High-Tech Gründerfonds. Transcatheter Technologies operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
- Headquarter Regensburg, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.7 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Venus MedTech
& 4 more
-
Employee Count
Not available
-
Acquired by
Venus MedTech
(Apr 18, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transcatheter Technologies
Transcatheter Technologies has successfully raised a total of $6.7M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Transcatheter Technologies
Transcatheter Technologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Venus MedTech, KfW and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked |
Investor details for Transcatheter Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Transcatheter Technologies
Investment portfolio details for Transcatheter Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Transcatheter Technologies
Detailed financials for Transcatheter Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transcatheter Technologies Comparisons
Peer comparison for Transcatheter Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Transcatheter Technologies
Transcatheter Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Minimally invasive heart valve replacement devices are developed and marketed.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
Detailed competitors of Transcatheter Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transcatheter Technologies
Complete news archive for Transcatheter Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transcatheter Technologies
Transcatheter Technologies was founded in 2009.
Transcatheter Technologies is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Transcatheter Technologies is a funded company, having raised a total of $6.7M across 4 funding rounds to date.
Transcatheter Technologies is a medical device company specializing in catheter-based heart valve implantation and aortic therapy. Key products in development are the transcatheter aortic valve implantation system TRINITY, the transcatheter mitral valve implant TRESILLO and the endovascular aortic repair stent TUMBAO.
Transcatheter Technologies's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Transcatheter Technologies has 5 investors. Key investors include Venus MedTech, KfW, High-Tech Gründerfonds, Tubaflex, and Bayern Kapital.